Biogen Inc.
289.930.90 (0.31%)

After hours: 290.000.07 (0.02%) as of 7:44 PM EDT

Interactive chart
  • 1d
  • 5d
  • 1m
  • 6m
  • YTD
  • 1y
  • 2y
  • 5y
  • 10y
  • Max
Prev Close289.03
Bid276.43 x 100
Ask290.54 x 100
52wk Range223.02 - 338.51
Day's Range286.80 - 290.46
Avg Vol (3m)1,880,711
As of 4:00 PM EDT. Market closed.
  • Investopediayesterday

    7 Quality Stocks That Don’t Pay a Dividend (PCLN)

    These seven S&P 500 companies can afford to pay a dividend, but they prefer to invest in growth.

  • Barrons.comyesterday

    Biotech Stocks: The End of Political Risk?

    RBC's Michael Yee and team contend that biotech stocks like Amgen (AMGN), Biogen (BIIB), Celgene (CELG), Gilead Sciences (GILD), and Alexion Pharmaceuticals (ALXN) are looking past the political risks: The SPDR S&P Biotech ETF (XBI) biotech index is up +13% in a month vs S&P500 +5% and we think political rhetoric and fear about drug pricing legislation which has been one of the primary overhangs on biotech stocks could be starting to move behind us as we go into H2:16. Indeed, given the large correction in the past year and rotation out of biotech, we think the market is starting to get more comfortable with the political environment and this could be an important shift and one of the key factors in driving stocks higher and removing the overhang.